Lataa...
Teriflunomide in patients with multiple sclerosis
The article discusses the prospects for the use of the new drug teriflunomide for the treatment of patients with relapsing-remitting multiple sclerosis. By now, phase II and III clinical trials are completed which demonstrated good tolerability, efficacy and relative safety of teriflunomide. The TEM...
Tallennettuna:
Päätekijät: | , |
---|---|
Aineistotyyppi: | Artigo |
Kieli: | Russo |
Julkaistu: |
Remedium Group LLC
2015-12-01
|
Sarja: | Медицинский совет |
Aiheet: | |
Linkit: | https://www.med-sovet.pro/jour/article/view/177 |
Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|